SCYNEXIS, Inc. Interest Expense
SCYNEXIS, Inc. (SCYX) reported Interest Expense of $197.00 thousand for the 3-month period ending 2024-06-30, per its 10-Q filed 2024-08-08.
Discontinued › Expense Statement › Interest Expense
us-gaap:InterestExpense · last filed 2024-08-08
- SCYNEXIS, Inc. interest expense for the quarter ending 2024-06-30 was $197.00K, a 84.23% decline year-over-year.
- SCYNEXIS, Inc. interest expense for the quarter ending 2024-03-31 was $205.00K, a 85.83% decline year-over-year.
- SCYNEXIS, Inc. interest expense for the quarter ending 2023-12-31 was $222.00K, a 85.48% decline year-over-year.
- SCYNEXIS, Inc. interest expense for the quarter ending 2023-09-30 was $212.00K, a 84.63% decline year-over-year.
- SCYNEXIS, Inc. interest expense for fiscal 2023 was $3.13M, a 39.78% decline from fiscal 2022.
- SCYNEXIS, Inc. interest expense for fiscal 2022 was $5.20M, a 95.41% increase from fiscal 2021.
- SCYNEXIS, Inc. interest expense for fiscal 2021 was $2.66M, a 125.23% increase from fiscal 2020.
- SCYNEXIS, Inc. interest expense for fiscal 2020 was $1.18M, a 19.78% increase from fiscal 2019.
| Period end | Interest Expense 3 month | Interest Expense 6 month | Interest Expense 9 month | Interest Expense 12 month |
|---|---|---|---|---|
| 2024-06-30 | $197.00K 10-Q · filed 2024-08-08 | $403.00K 10-Q · filed 2024-08-08 | $624.00K derived: sum of 3 quarters · filed 2024-08-08 | $836.00K derived: sum of 4 quarters · filed 2024-08-08 |
| 2024-03-31 | $205.00K 10-Q · filed 2024-05-08 | $427.00K derived: sum of 2 quarters · filed 2024-05-08 | $639.00K derived: sum of 3 quarters · filed 2024-05-08 | $1.89M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-12-31 | $222.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $434.00K derived: sum of 2 quarters · filed 2024-03-28 | $1.68M derived: sum of 3 quarters · filed 2024-08-08 | $3.13M 10-K · filed 2024-03-28 |
| 2023-09-30 | $212.00K 10-Q · filed 2023-11-13 | $1.46M derived: sum of 2 quarters · filed 2024-08-08 | $2.91M 10-Q · filed 2023-11-13 | $4.44M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-06-30 | $1.25M 10-Q · filed 2024-08-08 | $2.69M 10-Q · filed 2024-08-08 | $4.22M derived: sum of 3 quarters · filed 2024-08-08 | $5.60M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $1.45M 10-Q · filed 2024-05-08 | $2.98M derived: sum of 2 quarters · filed 2024-05-08 | $4.36M derived: sum of 3 quarters · filed 2024-05-08 | $5.59M derived: sum of 4 quarters · filed 2024-05-08 |
| 2022-12-31 | $1.53M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-28 | $2.91M derived: sum of 2 quarters · filed 2024-03-28 | $4.14M derived: sum of 3 quarters · filed 2024-03-28 | $5.20M 10-K · filed 2024-03-28 |
| 2022-09-30 | $1.38M 10-Q · filed 2023-11-13 | $2.61M derived: sum of 2 quarters · filed 2023-11-13 | $3.67M 10-Q · filed 2023-11-13 | $4.65M derived: sum of 4 quarters · filed 2023-11-13 |
| 2022-06-30 | $1.23M 10-Q · filed 2023-08-14 | $2.29M 10-Q · filed 2023-08-14 | $3.27M derived: sum of 3 quarters · filed 2023-08-14 | $4.29M derived: sum of 4 quarters · filed 2023-08-14 |
| 2022-03-31 | $1.06M 10-Q · filed 2023-05-10 | $2.04M derived: sum of 2 quarters · filed 2023-05-10 | $3.06M derived: sum of 3 quarters · filed 2023-05-10 | $3.50M derived: sum of 4 quarters · filed 2023-05-10 |
| 2021-12-31 | $982.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-31 | $2.00M derived: sum of 2 quarters · filed 2023-03-31 | $2.45M derived: sum of 3 quarters · filed 2023-03-31 | $2.66M 10-K · filed 2023-03-31 |
| 2021-09-30 | $1.02M 10-Q · filed 2022-11-09 | $1.46M derived: sum of 2 quarters · filed 2022-11-09 | $1.68M 10-Q · filed 2022-11-09 | $2.00M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $445.00K 10-Q · filed 2022-08-15 | $659.00K 10-Q · filed 2022-08-15 | $981.00K derived: sum of 3 quarters · filed 2022-08-15 | $1.31M derived: sum of 4 quarters · filed 2022-08-15 |
| 2021-03-31 | $214.00K 10-Q · filed 2022-05-12 | $536.00K derived: sum of 2 quarters · filed 2022-05-12 | $866.00K derived: sum of 3 quarters · filed 2022-05-12 | $1.19M derived: sum of 4 quarters · filed 2022-05-12 |
| 2020-12-31 | $322.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $652.00K derived: sum of 2 quarters · filed 2022-03-29 | $971.00K derived: sum of 3 quarters · filed 2022-03-29 | $1.18M 10-K · filed 2022-03-29 |
| 2020-09-30 | $330.00K 10-Q · filed 2021-11-10 | $649.00K derived: sum of 2 quarters · filed 2021-11-10 | $859.00K 10-Q · filed 2021-11-10 | $1.07M derived: sum of 4 quarters · filed 2021-11-10 |
| 2020-06-30 | $319.00K 10-Q · filed 2021-08-16 | $529.00K 10-Q · filed 2021-08-16 | $741.00K derived: sum of 3 quarters · filed 2021-08-16 | $944.00K derived: sum of 4 quarters · filed 2021-08-16 |
| 2020-03-31 | $210.00K 10-Q · filed 2021-05-17 | $422.00K derived: sum of 2 quarters · filed 2021-05-17 | $625.00K derived: sum of 3 quarters · filed 2021-05-17 | $834.00K derived: sum of 4 quarters · filed 2021-05-17 |
| 2019-12-31 | $212.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | $415.00K derived: sum of 2 quarters · filed 2021-03-29 | $624.00K derived: sum of 3 quarters · filed 2021-03-29 | $986.00K 10-K · filed 2021-03-29 |
| 2019-09-30 | $203.00K 10-Q · filed 2020-11-06 | $412.00K derived: sum of 2 quarters · filed 2020-11-06 | $774.00K 10-Q · filed 2020-11-06 | $1.19M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $209.00K 10-Q · filed 2020-08-10 | $574.00K 10-Q · filed 2020-08-10 | $991.00K derived: sum of 3 quarters · filed 2020-08-10 | $1.43M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $367.00K 10-Q · filed 2020-05-11 | $782.00K derived: sum of 2 quarters · filed 2020-05-11 | $1.22M derived: sum of 3 quarters · filed 2020-05-11 | $1.61M derived: sum of 4 quarters · filed 2020-05-11 |
| 2018-12-31 | $415.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-11 | $850.00K derived: sum of 2 quarters · filed 2020-03-11 | $1.25M derived: sum of 3 quarters · filed 2020-03-11 | $1.63M 10-K · filed 2020-03-11 |
| 2018-09-30 | $435.00K 10-Q · filed 2019-11-12 | $832.00K derived: sum of 2 quarters · filed 2019-11-12 | $1.21M 10-Q · filed 2019-11-12 | $1.58M derived: sum of 4 quarters · filed 2019-11-12 |
| 2018-06-30 | $397.00K 10-Q · filed 2019-08-07 | $776.00K 10-Q · filed 2019-08-07 | $1.15M derived: sum of 3 quarters · filed 2019-08-07 | $1.52M derived: sum of 4 quarters · filed 2019-08-07 |
| 2018-03-31 | $379.00K 10-Q · filed 2019-05-08 | $753.00K derived: sum of 2 quarters · filed 2019-05-08 | $1.13M derived: sum of 3 quarters · filed 2019-05-08 | $1.49M derived: sum of 4 quarters · filed 2019-05-08 |
| 2017-12-31 | $374.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-14 | $747.00K derived: sum of 2 quarters · filed 2019-03-14 | $1.11M derived: sum of 3 quarters · filed 2019-03-14 | $1.46M 10-K · filed 2019-03-14 |
| 2017-09-30 | $373.00K 10-Q · filed 2018-11-13 | $733.00K derived: sum of 2 quarters · filed 2018-11-13 | $1.08M 10-Q · filed 2018-11-13 | $1.43M derived: sum of 4 quarters · filed 2018-11-13 |
| 2017-06-30 | $360.00K 10-Q · filed 2018-08-09 | $709.00K 10-Q · filed 2018-08-09 | $1.06M derived: sum of 3 quarters · filed 2018-08-09 | $1.06M derived: sum of 4 quarters · filed 2018-08-09 |
| 2017-03-31 | $345.00K 10-Q · filed 2018-05-08 | $696.00K derived: sum of 2 quarters · filed 2018-05-08 | $696.00K derived: sum of 3 quarters · filed 2018-05-08 | $696.00K derived: sum of 4 quarters · filed 2018-05-08 |
| 2016-12-31 | $351.00K derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-13 | $351.00K derived: sum of 2 quarters · filed 2018-03-13 | $351.00K derived: sum of 3 quarters · filed 2018-03-13 | $351.00K 10-K · filed 2018-03-13 |
| 2016-09-30 | $0.00 10-Q · filed 2017-11-07 | $0.00 derived: sum of 2 quarters · filed 2017-11-07 | $0.00 10-Q · filed 2017-11-07 | |
| 2016-06-30 | $0.00 10-Q · filed 2017-08-08 | $0.00 10-Q · filed 2017-08-08 | ||
| 2016-03-31 | $0.00 10-Q · filed 2017-05-08 | |||
| 2015-12-31 | -$11.00K 10-K · filed 2017-03-13 | |||
| 2014-12-31 | $48.00K 10-K · filed 2017-03-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Werewolf Therapeutics, Inc. (HOWL) | United States | $0.047B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |